nodes	percent_of_prediction	percent_of_DWPC	metapath
Dabrafenib—ABCB1—Naltrexone—alcohol dependence	0.143	0.382	CbGbCtD
Dabrafenib—ABCB1—Citalopram—alcohol dependence	0.0946	0.253	CbGbCtD
Dabrafenib—CYP3A4—Disulfiram—alcohol dependence	0.0796	0.213	CbGbCtD
Dabrafenib—CYP3A4—Citalopram—alcohol dependence	0.0567	0.152	CbGbCtD
Dabrafenib—Dermatitis acneiform—Disulfiram—alcohol dependence	0.0165	0.0526	CcSEcCtD
Dabrafenib—Abdominal pain lower—Naltrexone—alcohol dependence	0.00827	0.0263	CcSEcCtD
Dabrafenib—Rash papular—Naltrexone—alcohol dependence	0.00706	0.0225	CcSEcCtD
Dabrafenib—NEK11—testis—alcohol dependence	0.00551	0.0395	CbGeAlD
Dabrafenib—Cardiomyopathy—Acamprosate—alcohol dependence	0.00543	0.0173	CcSEcCtD
Dabrafenib—Skin papilloma—Citalopram—alcohol dependence	0.00512	0.0163	CcSEcCtD
Dabrafenib—NEK11—cerebellum—alcohol dependence	0.00509	0.0365	CbGeAlD
Dabrafenib—Dermatitis acneiform—Citalopram—alcohol dependence	0.00488	0.0155	CcSEcCtD
Dabrafenib—Night sweats—Naltrexone—alcohol dependence	0.00487	0.0155	CcSEcCtD
Dabrafenib—LIMK1—blood—alcohol dependence	0.00477	0.0342	CbGeAlD
Dabrafenib—LIMK1—midbrain—alcohol dependence	0.00471	0.0338	CbGeAlD
Dabrafenib—NEK11—brain—alcohol dependence	0.00413	0.0296	CbGeAlD
Dabrafenib—LIMK1—testis—alcohol dependence	0.00394	0.0283	CbGeAlD
Dabrafenib—SIK1—forebrain—alcohol dependence	0.00369	0.0264	CbGeAlD
Dabrafenib—LIMK1—cerebellum—alcohol dependence	0.00364	0.0261	CbGeAlD
Dabrafenib—Eye haemorrhage—Citalopram—alcohol dependence	0.00356	0.0113	CcSEcCtD
Dabrafenib—Rash pustular—Acamprosate—alcohol dependence	0.00349	0.0111	CcSEcCtD
Dabrafenib—Abdominal discomfort—Disulfiram—alcohol dependence	0.0034	0.0108	CcSEcCtD
Dabrafenib—Lymphopenia—Citalopram—alcohol dependence	0.00326	0.0104	CcSEcCtD
Dabrafenib—Rigors—Naltrexone—alcohol dependence	0.00322	0.0103	CcSEcCtD
Dabrafenib—Gamma-glutamyltransferase increased—Naltrexone—alcohol dependence	0.0032	0.0102	CcSEcCtD
Dabrafenib—Night sweats—Citalopram—alcohol dependence	0.00309	0.00983	CcSEcCtD
Dabrafenib—Hyperbilirubinaemia—Acamprosate—alcohol dependence	0.00306	0.00973	CcSEcCtD
Dabrafenib—RAF1—brainstem—alcohol dependence	0.00304	0.0218	CbGeAlD
Dabrafenib—SIK1—pancreas—alcohol dependence	0.00303	0.0217	CbGeAlD
Dabrafenib—LIMK1—brain—alcohol dependence	0.00296	0.0212	CbGeAlD
Dabrafenib—BRAF—blood—alcohol dependence	0.00294	0.0211	CbGeAlD
Dabrafenib—Gingival bleeding—Citalopram—alcohol dependence	0.00294	0.00935	CcSEcCtD
Dabrafenib—RAF1—forebrain—alcohol dependence	0.00293	0.021	CbGeAlD
Dabrafenib—Creatinine increased—Acamprosate—alcohol dependence	0.00292	0.0093	CcSEcCtD
Dabrafenib—BRAF—midbrain—alcohol dependence	0.00291	0.0209	CbGeAlD
Dabrafenib—Cellulitis—Naltrexone—alcohol dependence	0.00289	0.00921	CcSEcCtD
Dabrafenib—Oropharyngeal pain—Naltrexone—alcohol dependence	0.00289	0.00921	CcSEcCtD
Dabrafenib—SIK1—gonad—alcohol dependence	0.00283	0.0203	CbGeAlD
Dabrafenib—Phosphatase alkaline increased—Acamprosate—alcohol dependence	0.00278	0.00885	CcSEcCtD
Dabrafenib—Polyp—Citalopram—alcohol dependence	0.00274	0.00872	CcSEcCtD
Dabrafenib—RAF1—adrenal cortex—alcohol dependence	0.00272	0.0195	CbGeAlD
Dabrafenib—Folliculitis—Citalopram—alcohol dependence	0.00265	0.00844	CcSEcCtD
Dabrafenib—Electrocardiogram QT prolonged—Citalopram—alcohol dependence	0.0026	0.00826	CcSEcCtD
Dabrafenib—Rash maculo-papular—Acamprosate—alcohol dependence	0.00253	0.00804	CcSEcCtD
Dabrafenib—Cyst—Citalopram—alcohol dependence	0.00249	0.00794	CcSEcCtD
Dabrafenib—RAF1—cardiovascular system—alcohol dependence	0.00248	0.0178	CbGeAlD
Dabrafenib—SIK1—blood—alcohol dependence	0.00246	0.0177	CbGeAlD
Dabrafenib—BRAF—testis—alcohol dependence	0.00244	0.0175	CbGeAlD
Dabrafenib—RAF1—pancreas—alcohol dependence	0.00241	0.0173	CbGeAlD
Dabrafenib—Blood alkaline phosphatase increased—Acamprosate—alcohol dependence	0.00232	0.00739	CcSEcCtD
Dabrafenib—BRAF—liver—alcohol dependence	0.0023	0.0165	CbGeAlD
Dabrafenib—Vaginal haemorrhage—Citalopram—alcohol dependence	0.00225	0.00717	CcSEcCtD
Dabrafenib—RAF1—gonad—alcohol dependence	0.00225	0.0162	CbGeAlD
Dabrafenib—BRAF—cerebellum—alcohol dependence	0.00225	0.0161	CbGeAlD
Dabrafenib—SLCO1B3—endocrine gland—alcohol dependence	0.0022	0.0158	CbGeAlD
Dabrafenib—Renal failure acute—Acamprosate—alcohol dependence	0.00219	0.00696	CcSEcCtD
Dabrafenib—Rash erythematous—Citalopram—alcohol dependence	0.00218	0.00693	CcSEcCtD
Dabrafenib—SIK1—endocrine gland—alcohol dependence	0.00214	0.0153	CbGeAlD
Dabrafenib—Dermatitis bullous—Acamprosate—alcohol dependence	0.00211	0.00672	CcSEcCtD
Dabrafenib—Cardiac failure congestive—Naltrexone—alcohol dependence	0.00211	0.0067	CcSEcCtD
Dabrafenib—Rash pustular—Citalopram—alcohol dependence	0.00209	0.00665	CcSEcCtD
Dabrafenib—RAF1—digestive system—alcohol dependence	0.00206	0.0148	CbGeAlD
Dabrafenib—Rigors—Citalopram—alcohol dependence	0.00204	0.0065	CcSEcCtD
Dabrafenib—SIK1—testis—alcohol dependence	0.00204	0.0146	CbGeAlD
Dabrafenib—Hyponatraemia—Acamprosate—alcohol dependence	0.00203	0.00645	CcSEcCtD
Dabrafenib—Gamma-glutamyltransferase increased—Citalopram—alcohol dependence	0.00203	0.00645	CcSEcCtD
Dabrafenib—SIK1—nervous system—alcohol dependence	0.002	0.0144	CbGeAlD
Dabrafenib—SLCO1B3—liver—alcohol dependence	0.00198	0.0142	CbGeAlD
Dabrafenib—RAF1—blood—alcohol dependence	0.00196	0.0141	CbGeAlD
Dabrafenib—RAF1—midbrain—alcohol dependence	0.00194	0.0139	CbGeAlD
Dabrafenib—SIK1—liver—alcohol dependence	0.00193	0.0138	CbGeAlD
Dabrafenib—SIK1—central nervous system—alcohol dependence	0.00193	0.0138	CbGeAlD
Dabrafenib—Pain in extremity—Naltrexone—alcohol dependence	0.00191	0.00608	CcSEcCtD
Dabrafenib—Blood creatinine increased—Acamprosate—alcohol dependence	0.00189	0.00602	CcSEcCtD
Dabrafenib—SIK1—cerebellum—alcohol dependence	0.00188	0.0135	CbGeAlD
Dabrafenib—Dry skin—Acamprosate—alcohol dependence	0.00185	0.00589	CcSEcCtD
Dabrafenib—Bone disorder—Citalopram—alcohol dependence	0.00185	0.00587	CcSEcCtD
Dabrafenib—Cellulitis—Citalopram—alcohol dependence	0.00183	0.00583	CcSEcCtD
Dabrafenib—Hyperbilirubinaemia—Citalopram—alcohol dependence	0.00183	0.00583	CcSEcCtD
Dabrafenib—BRAF—brain—alcohol dependence	0.00183	0.0131	CbGeAlD
Dabrafenib—Hypocalcaemia—Citalopram—alcohol dependence	0.00182	0.0058	CcSEcCtD
Dabrafenib—Aspartate aminotransferase increased—Acamprosate—alcohol dependence	0.00182	0.00578	CcSEcCtD
Dabrafenib—Alanine aminotransferase increased—Acamprosate—alcohol dependence	0.00178	0.00567	CcSEcCtD
Dabrafenib—Dehydration—Naltrexone—alcohol dependence	0.00178	0.00565	CcSEcCtD
Dabrafenib—Abdominal pain upper—Naltrexone—alcohol dependence	0.00174	0.00555	CcSEcCtD
Dabrafenib—Fatigue—Disulfiram—alcohol dependence	0.00174	0.00553	CcSEcCtD
Dabrafenib—Aspartate aminotransferase increased—Naltrexone—alcohol dependence	0.00172	0.00547	CcSEcCtD
Dabrafenib—Pancreatitis—Acamprosate—alcohol dependence	0.00171	0.00544	CcSEcCtD
Dabrafenib—Nasopharyngitis—Naltrexone—alcohol dependence	0.00171	0.00544	CcSEcCtD
Dabrafenib—RAF1—endocrine gland—alcohol dependence	0.0017	0.0122	CbGeAlD
Dabrafenib—Alanine aminotransferase increased—Naltrexone—alcohol dependence	0.00168	0.00536	CcSEcCtD
Dabrafenib—Phosphatase alkaline increased—Citalopram—alcohol dependence	0.00167	0.00531	CcSEcCtD
Dabrafenib—RAF1—testis—alcohol dependence	0.00162	0.0116	CbGeAlD
Dabrafenib—Influenza like illness—Citalopram—alcohol dependence	0.00162	0.00515	CcSEcCtD
Dabrafenib—RAF1—nervous system—alcohol dependence	0.00159	0.0114	CbGeAlD
Dabrafenib—Abdominal discomfort—Naltrexone—alcohol dependence	0.00158	0.00504	CcSEcCtD
Dabrafenib—Hyperglycaemia—Acamprosate—alcohol dependence	0.00157	0.00501	CcSEcCtD
Dabrafenib—SLCO1B1—digestive system—alcohol dependence	0.00154	0.0111	CbGeAlD
Dabrafenib—RAF1—liver—alcohol dependence	0.00153	0.011	CbGeAlD
Dabrafenib—RAF1—central nervous system—alcohol dependence	0.00153	0.011	CbGeAlD
Dabrafenib—SIK1—brain—alcohol dependence	0.00153	0.011	CbGeAlD
Dabrafenib—Stomatitis—Acamprosate—alcohol dependence	0.00152	0.00483	CcSEcCtD
Dabrafenib—Rash maculo-papular—Citalopram—alcohol dependence	0.00152	0.00482	CcSEcCtD
Dabrafenib—Urinary tract infection—Acamprosate—alcohol dependence	0.00151	0.00481	CcSEcCtD
Dabrafenib—Neoplasm—Citalopram—alcohol dependence	0.00151	0.0048	CcSEcCtD
Dabrafenib—RAF1—cerebellum—alcohol dependence	0.0015	0.0108	CbGeAlD
Dabrafenib—Haematuria—Acamprosate—alcohol dependence	0.00148	0.00472	CcSEcCtD
Dabrafenib—Infestation—Naltrexone—alcohol dependence	0.00147	0.00468	CcSEcCtD
Dabrafenib—Infestation NOS—Naltrexone—alcohol dependence	0.00147	0.00468	CcSEcCtD
Dabrafenib—SLCO1B1—blood—alcohol dependence	0.00147	0.0105	CbGeAlD
Dabrafenib—Epistaxis—Acamprosate—alcohol dependence	0.00147	0.00467	CcSEcCtD
Dabrafenib—Asthenia—Disulfiram—alcohol dependence	0.00145	0.0046	CcSEcCtD
Dabrafenib—Urinary tract infection—Naltrexone—alcohol dependence	0.00143	0.00455	CcSEcCtD
Dabrafenib—Haemoglobin—Acamprosate—alcohol dependence	0.0014	0.00447	CcSEcCtD
Dabrafenib—Haemorrhage—Acamprosate—alcohol dependence	0.0014	0.00444	CcSEcCtD
Dabrafenib—Blood alkaline phosphatase increased—Citalopram—alcohol dependence	0.00139	0.00443	CcSEcCtD
Dabrafenib—Epistaxis—Naltrexone—alcohol dependence	0.00139	0.00442	CcSEcCtD
Dabrafenib—Oedema peripheral—Acamprosate—alcohol dependence	0.00138	0.00438	CcSEcCtD
Dabrafenib—Dizziness—Disulfiram—alcohol dependence	0.00133	0.00424	CcSEcCtD
Dabrafenib—Renal failure acute—Citalopram—alcohol dependence	0.00131	0.00417	CcSEcCtD
Dabrafenib—Connective tissue disorder—Naltrexone—alcohol dependence	0.0013	0.00413	CcSEcCtD
Dabrafenib—SLCO1B1—endocrine gland—alcohol dependence	0.00127	0.00913	CbGeAlD
Dabrafenib—Rash—Disulfiram—alcohol dependence	0.00127	0.00404	CcSEcCtD
Dabrafenib—Dermatitis bullous—Citalopram—alcohol dependence	0.00127	0.00403	CcSEcCtD
Dabrafenib—Headache—Disulfiram—alcohol dependence	0.00126	0.00402	CcSEcCtD
Dabrafenib—Immune system disorder—Acamprosate—alcohol dependence	0.00126	0.00401	CcSEcCtD
Dabrafenib—Chills—Acamprosate—alcohol dependence	0.00125	0.00399	CcSEcCtD
Dabrafenib—Eye disorder—Naltrexone—alcohol dependence	0.00123	0.00393	CcSEcCtD
Dabrafenib—Alopecia—Acamprosate—alcohol dependence	0.00123	0.00393	CcSEcCtD
Dabrafenib—Mental disorder—Acamprosate—alcohol dependence	0.00122	0.00389	CcSEcCtD
Dabrafenib—RAF1—brain—alcohol dependence	0.00122	0.00873	CbGeAlD
Dabrafenib—Malnutrition—Acamprosate—alcohol dependence	0.00122	0.00387	CcSEcCtD
Dabrafenib—Hyponatraemia—Citalopram—alcohol dependence	0.00122	0.00387	CcSEcCtD
Dabrafenib—Pain in extremity—Citalopram—alcohol dependence	0.00121	0.00385	CcSEcCtD
Dabrafenib—Angiopathy—Naltrexone—alcohol dependence	0.0012	0.00381	CcSEcCtD
Dabrafenib—Immune system disorder—Naltrexone—alcohol dependence	0.00119	0.0038	CcSEcCtD
Dabrafenib—Mediastinal disorder—Naltrexone—alcohol dependence	0.00119	0.00379	CcSEcCtD
Dabrafenib—Chills—Naltrexone—alcohol dependence	0.00119	0.00377	CcSEcCtD
Dabrafenib—SLC22A6—brain—alcohol dependence	0.00118	0.00848	CbGeAlD
Dabrafenib—Back pain—Acamprosate—alcohol dependence	0.00118	0.00374	CcSEcCtD
Dabrafenib—Muscle spasms—Acamprosate—alcohol dependence	0.00117	0.00372	CcSEcCtD
Dabrafenib—Alopecia—Naltrexone—alcohol dependence	0.00117	0.00372	CcSEcCtD
Dabrafenib—Mental disorder—Naltrexone—alcohol dependence	0.00116	0.00368	CcSEcCtD
Dabrafenib—Malnutrition—Naltrexone—alcohol dependence	0.00115	0.00366	CcSEcCtD
Dabrafenib—SLCO1B1—liver—alcohol dependence	0.00115	0.00823	CbGeAlD
Dabrafenib—SLC22A8—blood—alcohol dependence	0.00114	0.00818	CbGeAlD
Dabrafenib—Dehydration—Citalopram—alcohol dependence	0.00113	0.00358	CcSEcCtD
Dabrafenib—ABCG2—adrenal cortex—alcohol dependence	0.00112	0.00807	CbGeAlD
Dabrafenib—Anaemia—Acamprosate—alcohol dependence	0.00112	0.00358	CcSEcCtD
Dabrafenib—Back pain—Naltrexone—alcohol dependence	0.00111	0.00354	CcSEcCtD
Dabrafenib—Dry skin—Citalopram—alcohol dependence	0.00111	0.00353	CcSEcCtD
Dabrafenib—Muscle spasms—Naltrexone—alcohol dependence	0.00111	0.00352	CcSEcCtD
Dabrafenib—Abdominal pain upper—Citalopram—alcohol dependence	0.00111	0.00352	CcSEcCtD
Dabrafenib—Hypokalaemia—Citalopram—alcohol dependence	0.0011	0.0035	CcSEcCtD
Dabrafenib—Aspartate aminotransferase increased—Citalopram—alcohol dependence	0.00109	0.00347	CcSEcCtD
Dabrafenib—Leukopenia—Acamprosate—alcohol dependence	0.00109	0.00346	CcSEcCtD
Dabrafenib—Vision blurred—Naltrexone—alcohol dependence	0.00108	0.00345	CcSEcCtD
Dabrafenib—Nasopharyngitis—Citalopram—alcohol dependence	0.00108	0.00344	CcSEcCtD
Dabrafenib—Alanine aminotransferase increased—Citalopram—alcohol dependence	0.00107	0.0034	CcSEcCtD
Dabrafenib—Cough—Acamprosate—alcohol dependence	0.00106	0.00338	CcSEcCtD
Dabrafenib—Hypertension—Acamprosate—alcohol dependence	0.00105	0.00334	CcSEcCtD
Dabrafenib—Arthralgia—Acamprosate—alcohol dependence	0.00103	0.00329	CcSEcCtD
Dabrafenib—Myalgia—Acamprosate—alcohol dependence	0.00103	0.00329	CcSEcCtD
Dabrafenib—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	0.00103	0.00327	CcSEcCtD
Dabrafenib—Pancreatitis—Citalopram—alcohol dependence	0.00103	0.00326	CcSEcCtD
Dabrafenib—Dry mouth—Acamprosate—alcohol dependence	0.00101	0.00322	CcSEcCtD
Dabrafenib—Cough—Naltrexone—alcohol dependence	0.001	0.00319	CcSEcCtD
Dabrafenib—Abdominal discomfort—Citalopram—alcohol dependence	0.001	0.00319	CcSEcCtD
Dabrafenib—Hypertension—Naltrexone—alcohol dependence	0.000993	0.00316	CcSEcCtD
Dabrafenib—Infection—Acamprosate—alcohol dependence	0.000986	0.00314	CcSEcCtD
Dabrafenib—Arthralgia—Naltrexone—alcohol dependence	0.000979	0.00312	CcSEcCtD
Dabrafenib—Myalgia—Naltrexone—alcohol dependence	0.000979	0.00312	CcSEcCtD
Dabrafenib—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	0.000972	0.00309	CcSEcCtD
Dabrafenib—Thrombocytopenia—Acamprosate—alcohol dependence	0.000971	0.00309	CcSEcCtD
Dabrafenib—Skin disorder—Acamprosate—alcohol dependence	0.000964	0.00307	CcSEcCtD
Dabrafenib—Hyperhidrosis—Acamprosate—alcohol dependence	0.000959	0.00305	CcSEcCtD
Dabrafenib—Dry mouth—Naltrexone—alcohol dependence	0.000958	0.00305	CcSEcCtD
Dabrafenib—Hyperglycaemia—Citalopram—alcohol dependence	0.000943	0.003	CcSEcCtD
Dabrafenib—Oedema—Naltrexone—alcohol dependence	0.000939	0.00299	CcSEcCtD
Dabrafenib—Infection—Naltrexone—alcohol dependence	0.000933	0.00297	CcSEcCtD
Dabrafenib—Infestation NOS—Citalopram—alcohol dependence	0.000933	0.00297	CcSEcCtD
Dabrafenib—Infestation—Citalopram—alcohol dependence	0.000933	0.00297	CcSEcCtD
Dabrafenib—Hypotension—Acamprosate—alcohol dependence	0.000927	0.00295	CcSEcCtD
Dabrafenib—SLC22A8—nervous system—alcohol dependence	0.000926	0.00664	CbGeAlD
Dabrafenib—Nervous system disorder—Naltrexone—alcohol dependence	0.000921	0.00293	CcSEcCtD
Dabrafenib—Skin disorder—Naltrexone—alcohol dependence	0.000912	0.0029	CcSEcCtD
Dabrafenib—Stomatitis—Citalopram—alcohol dependence	0.000909	0.00289	CcSEcCtD
Dabrafenib—Hyperhidrosis—Naltrexone—alcohol dependence	0.000907	0.00289	CcSEcCtD
Dabrafenib—Urinary tract infection—Citalopram—alcohol dependence	0.000906	0.00288	CcSEcCtD
Dabrafenib—Musculoskeletal discomfort—Acamprosate—alcohol dependence	0.000904	0.00288	CcSEcCtD
Dabrafenib—Insomnia—Acamprosate—alcohol dependence	0.000897	0.00286	CcSEcCtD
Dabrafenib—SLC22A8—central nervous system—alcohol dependence	0.000891	0.00639	CbGeAlD
Dabrafenib—Haematuria—Citalopram—alcohol dependence	0.000889	0.00283	CcSEcCtD
Dabrafenib—Epistaxis—Citalopram—alcohol dependence	0.00088	0.0028	CcSEcCtD
Dabrafenib—Decreased appetite—Acamprosate—alcohol dependence	0.000862	0.00274	CcSEcCtD
Dabrafenib—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.000857	0.00273	CcSEcCtD
Dabrafenib—Musculoskeletal discomfort—Naltrexone—alcohol dependence	0.000855	0.00272	CcSEcCtD
Dabrafenib—Insomnia—Naltrexone—alcohol dependence	0.000849	0.0027	CcSEcCtD
Dabrafenib—Constipation—Acamprosate—alcohol dependence	0.000848	0.0027	CcSEcCtD
Dabrafenib—Haemoglobin—Citalopram—alcohol dependence	0.000841	0.00268	CcSEcCtD
Dabrafenib—Haemorrhage—Citalopram—alcohol dependence	0.000837	0.00266	CcSEcCtD
Dabrafenib—CYP2C8—blood—alcohol dependence	0.000834	0.00599	CbGeAlD
Dabrafenib—Urinary tract disorder—Citalopram—alcohol dependence	0.000827	0.00263	CcSEcCtD
Dabrafenib—Oedema peripheral—Citalopram—alcohol dependence	0.000825	0.00262	CcSEcCtD
Dabrafenib—Connective tissue disorder—Citalopram—alcohol dependence	0.000823	0.00262	CcSEcCtD
Dabrafenib—Urethral disorder—Citalopram—alcohol dependence	0.000821	0.00261	CcSEcCtD
Dabrafenib—Decreased appetite—Naltrexone—alcohol dependence	0.000816	0.0026	CcSEcCtD
Dabrafenib—ABCG2—blood—alcohol dependence	0.000811	0.00582	CbGeAlD
Dabrafenib—Gastrointestinal pain—Acamprosate—alcohol dependence	0.000811	0.00258	CcSEcCtD
Dabrafenib—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.00081	0.00258	CcSEcCtD
Dabrafenib—Fatigue—Naltrexone—alcohol dependence	0.000809	0.00258	CcSEcCtD
Dabrafenib—Constipation—Naltrexone—alcohol dependence	0.000803	0.00255	CcSEcCtD
Dabrafenib—ABCG2—midbrain—alcohol dependence	0.000801	0.00575	CbGeAlD
Dabrafenib—Body temperature increased—Acamprosate—alcohol dependence	0.000784	0.0025	CcSEcCtD
Dabrafenib—Abdominal pain—Acamprosate—alcohol dependence	0.000784	0.0025	CcSEcCtD
Dabrafenib—Eye disorder—Citalopram—alcohol dependence	0.000782	0.00249	CcSEcCtD
Dabrafenib—Gastrointestinal pain—Naltrexone—alcohol dependence	0.000768	0.00244	CcSEcCtD
Dabrafenib—Angiopathy—Citalopram—alcohol dependence	0.00076	0.00242	CcSEcCtD
Dabrafenib—Immune system disorder—Citalopram—alcohol dependence	0.000756	0.00241	CcSEcCtD
Dabrafenib—Mediastinal disorder—Citalopram—alcohol dependence	0.000754	0.0024	CcSEcCtD
Dabrafenib—Chills—Citalopram—alcohol dependence	0.000751	0.00239	CcSEcCtD
Dabrafenib—Arrhythmia—Citalopram—alcohol dependence	0.000748	0.00238	CcSEcCtD
Dabrafenib—Abdominal pain—Naltrexone—alcohol dependence	0.000742	0.00236	CcSEcCtD
Dabrafenib—Body temperature increased—Naltrexone—alcohol dependence	0.000742	0.00236	CcSEcCtD
Dabrafenib—Alopecia—Citalopram—alcohol dependence	0.00074	0.00235	CcSEcCtD
Dabrafenib—Mental disorder—Citalopram—alcohol dependence	0.000733	0.00233	CcSEcCtD
Dabrafenib—Hypersensitivity—Acamprosate—alcohol dependence	0.000731	0.00233	CcSEcCtD
Dabrafenib—Erythema—Citalopram—alcohol dependence	0.000729	0.00232	CcSEcCtD
Dabrafenib—Malnutrition—Citalopram—alcohol dependence	0.000729	0.00232	CcSEcCtD
Dabrafenib—CYP2C8—endocrine gland—alcohol dependence	0.000724	0.00519	CbGeAlD
Dabrafenib—Asthenia—Acamprosate—alcohol dependence	0.000712	0.00227	CcSEcCtD
Dabrafenib—SLC22A8—brain—alcohol dependence	0.000708	0.00508	CbGeAlD
Dabrafenib—Back pain—Citalopram—alcohol dependence	0.000705	0.00224	CcSEcCtD
Dabrafenib—Pruritus—Acamprosate—alcohol dependence	0.000702	0.00223	CcSEcCtD
Dabrafenib—Muscle spasms—Citalopram—alcohol dependence	0.000701	0.00223	CcSEcCtD
Dabrafenib—Hypersensitivity—Naltrexone—alcohol dependence	0.000692	0.0022	CcSEcCtD
Dabrafenib—CYP2C8—testis—alcohol dependence	0.00069	0.00495	CbGeAlD
Dabrafenib—Vision blurred—Citalopram—alcohol dependence	0.000687	0.00219	CcSEcCtD
Dabrafenib—Diarrhoea—Acamprosate—alcohol dependence	0.000679	0.00216	CcSEcCtD
Dabrafenib—Anaemia—Citalopram—alcohol dependence	0.000674	0.00214	CcSEcCtD
Dabrafenib—Asthenia—Naltrexone—alcohol dependence	0.000674	0.00214	CcSEcCtD
Dabrafenib—ABCG2—testis—alcohol dependence	0.000671	0.00482	CbGeAlD
Dabrafenib—Pruritus—Naltrexone—alcohol dependence	0.000664	0.00211	CcSEcCtD
Dabrafenib—Dizziness—Acamprosate—alcohol dependence	0.000656	0.00209	CcSEcCtD
Dabrafenib—CYP2C8—liver—alcohol dependence	0.000653	0.00468	CbGeAlD
Dabrafenib—Leukopenia—Citalopram—alcohol dependence	0.000652	0.00208	CcSEcCtD
Dabrafenib—Diarrhoea—Naltrexone—alcohol dependence	0.000642	0.00204	CcSEcCtD
Dabrafenib—Cough—Citalopram—alcohol dependence	0.000636	0.00202	CcSEcCtD
Dabrafenib—ABCG2—liver—alcohol dependence	0.000634	0.00455	CbGeAlD
Dabrafenib—Vomiting—Acamprosate—alcohol dependence	0.000631	0.00201	CcSEcCtD
Dabrafenib—Hypertension—Citalopram—alcohol dependence	0.000629	0.002	CcSEcCtD
Dabrafenib—Rash—Acamprosate—alcohol dependence	0.000626	0.00199	CcSEcCtD
Dabrafenib—Dermatitis—Acamprosate—alcohol dependence	0.000625	0.00199	CcSEcCtD
Dabrafenib—Headache—Acamprosate—alcohol dependence	0.000622	0.00198	CcSEcCtD
Dabrafenib—Dizziness—Naltrexone—alcohol dependence	0.000621	0.00198	CcSEcCtD
Dabrafenib—Arthralgia—Citalopram—alcohol dependence	0.00062	0.00197	CcSEcCtD
Dabrafenib—Myalgia—Citalopram—alcohol dependence	0.00062	0.00197	CcSEcCtD
Dabrafenib—ABCG2—cerebellum—alcohol dependence	0.00062	0.00445	CbGeAlD
Dabrafenib—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	0.000616	0.00196	CcSEcCtD
Dabrafenib—Dry mouth—Citalopram—alcohol dependence	0.000607	0.00193	CcSEcCtD
Dabrafenib—ABCB1—forebrain—alcohol dependence	0.000598	0.00429	CbGeAlD
Dabrafenib—Vomiting—Naltrexone—alcohol dependence	0.000597	0.0019	CcSEcCtD
Dabrafenib—Oedema—Citalopram—alcohol dependence	0.000595	0.00189	CcSEcCtD
Dabrafenib—CYP3A4—digestive system—alcohol dependence	0.000593	0.00426	CbGeAlD
Dabrafenib—Rash—Naltrexone—alcohol dependence	0.000592	0.00188	CcSEcCtD
Dabrafenib—Dermatitis—Naltrexone—alcohol dependence	0.000591	0.00188	CcSEcCtD
Dabrafenib—Infection—Citalopram—alcohol dependence	0.000591	0.00188	CcSEcCtD
Dabrafenib—Nausea—Acamprosate—alcohol dependence	0.000589	0.00188	CcSEcCtD
Dabrafenib—Headache—Naltrexone—alcohol dependence	0.000588	0.00187	CcSEcCtD
Dabrafenib—Nervous system disorder—Citalopram—alcohol dependence	0.000583	0.00186	CcSEcCtD
Dabrafenib—Thrombocytopenia—Citalopram—alcohol dependence	0.000582	0.00185	CcSEcCtD
Dabrafenib—Skin disorder—Citalopram—alcohol dependence	0.000578	0.00184	CcSEcCtD
Dabrafenib—Hyperhidrosis—Citalopram—alcohol dependence	0.000575	0.00183	CcSEcCtD
Dabrafenib—CYP3A4—blood—alcohol dependence	0.000565	0.00406	CbGeAlD
Dabrafenib—Nausea—Naltrexone—alcohol dependence	0.000558	0.00177	CcSEcCtD
Dabrafenib—Hypotension—Citalopram—alcohol dependence	0.000556	0.00177	CcSEcCtD
Dabrafenib—ABCB1—adrenal cortex—alcohol dependence	0.000554	0.00398	CbGeAlD
Dabrafenib—Musculoskeletal discomfort—Citalopram—alcohol dependence	0.000542	0.00172	CcSEcCtD
Dabrafenib—Insomnia—Citalopram—alcohol dependence	0.000538	0.00171	CcSEcCtD
Dabrafenib—CYP2C8—brain—alcohol dependence	0.000518	0.00372	CbGeAlD
Dabrafenib—Decreased appetite—Citalopram—alcohol dependence	0.000517	0.00165	CcSEcCtD
Dabrafenib—Gastrointestinal disorder—Citalopram—alcohol dependence	0.000513	0.00163	CcSEcCtD
Dabrafenib—Fatigue—Citalopram—alcohol dependence	0.000513	0.00163	CcSEcCtD
Dabrafenib—Constipation—Citalopram—alcohol dependence	0.000509	0.00162	CcSEcCtD
Dabrafenib—ABCB1—cardiovascular system—alcohol dependence	0.000506	0.00363	CbGeAlD
Dabrafenib—ABCG2—brain—alcohol dependence	0.000503	0.00361	CbGeAlD
Dabrafenib—ABCB1—pancreas—alcohol dependence	0.000492	0.00353	CbGeAlD
Dabrafenib—CYP3A4—endocrine gland—alcohol dependence	0.00049	0.00352	CbGeAlD
Dabrafenib—Gastrointestinal pain—Citalopram—alcohol dependence	0.000486	0.00155	CcSEcCtD
Dabrafenib—Abdominal pain—Citalopram—alcohol dependence	0.00047	0.0015	CcSEcCtD
Dabrafenib—Body temperature increased—Citalopram—alcohol dependence	0.00047	0.0015	CcSEcCtD
Dabrafenib—ABCB1—gonad—alcohol dependence	0.000459	0.00329	CbGeAlD
Dabrafenib—CYP3A4—nervous system—alcohol dependence	0.000459	0.00329	CbGeAlD
Dabrafenib—CYP3A4—liver—alcohol dependence	0.000442	0.00317	CbGeAlD
Dabrafenib—CYP3A4—central nervous system—alcohol dependence	0.000442	0.00317	CbGeAlD
Dabrafenib—Hypersensitivity—Citalopram—alcohol dependence	0.000438	0.00139	CcSEcCtD
Dabrafenib—Asthenia—Citalopram—alcohol dependence	0.000427	0.00136	CcSEcCtD
Dabrafenib—Pruritus—Citalopram—alcohol dependence	0.000421	0.00134	CcSEcCtD
Dabrafenib—ABCB1—digestive system—alcohol dependence	0.00042	0.00301	CbGeAlD
Dabrafenib—Diarrhoea—Citalopram—alcohol dependence	0.000407	0.0013	CcSEcCtD
Dabrafenib—ABCB1—blood—alcohol dependence	0.0004	0.00287	CbGeAlD
Dabrafenib—ABCB1—midbrain—alcohol dependence	0.000395	0.00283	CbGeAlD
Dabrafenib—Dizziness—Citalopram—alcohol dependence	0.000393	0.00125	CcSEcCtD
Dabrafenib—Vomiting—Citalopram—alcohol dependence	0.000378	0.0012	CcSEcCtD
Dabrafenib—Rash—Citalopram—alcohol dependence	0.000375	0.00119	CcSEcCtD
Dabrafenib—Dermatitis—Citalopram—alcohol dependence	0.000375	0.00119	CcSEcCtD
Dabrafenib—Headache—Citalopram—alcohol dependence	0.000373	0.00119	CcSEcCtD
Dabrafenib—Nausea—Citalopram—alcohol dependence	0.000353	0.00112	CcSEcCtD
Dabrafenib—ABCB1—endocrine gland—alcohol dependence	0.000347	0.00249	CbGeAlD
Dabrafenib—ABCB1—testis—alcohol dependence	0.000331	0.00237	CbGeAlD
Dabrafenib—ABCB1—nervous system—alcohol dependence	0.000325	0.00233	CbGeAlD
Dabrafenib—ABCB1—liver—alcohol dependence	0.000313	0.00224	CbGeAlD
Dabrafenib—ABCB1—central nervous system—alcohol dependence	0.000313	0.00224	CbGeAlD
Dabrafenib—ABCB1—cerebellum—alcohol dependence	0.000306	0.00219	CbGeAlD
Dabrafenib—CYP2C8—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.00027	0.00157	CbGpPWpGaD
Dabrafenib—RAF1—Kit receptor signaling pathway—EP300—alcohol dependence	0.00027	0.00156	CbGpPWpGaD
Dabrafenib—CYP3A4—Tryptophan metabolism—CYP2E1—alcohol dependence	0.000269	0.00156	CbGpPWpGaD
Dabrafenib—CYP3A4—Biological oxidations—ADH1A—alcohol dependence	0.000262	0.00152	CbGpPWpGaD
Dabrafenib—SLCO1B3—SLC-mediated transmembrane transport—AVP—alcohol dependence	0.000262	0.00152	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—ADH6—alcohol dependence	0.000261	0.00151	CbGpPWpGaD
Dabrafenib—BRAF—Neuronal System—MAOA—alcohol dependence	0.00026	0.00151	CbGpPWpGaD
Dabrafenib—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000259	0.0015	CbGpPWpGaD
Dabrafenib—CYP2C8—Biological oxidations—MAOB—alcohol dependence	0.000257	0.00149	CbGpPWpGaD
Dabrafenib—SLC22A8—Transmembrane transport of small molecules—GABRA2—alcohol dependence	0.000251	0.00146	CbGpPWpGaD
Dabrafenib—ABCB1—brain—alcohol dependence	0.000248	0.00178	CbGeAlD
Dabrafenib—SLC22A6—Transmembrane transport of small molecules—GABRB1—alcohol dependence	0.000247	0.00143	CbGpPWpGaD
Dabrafenib—RAF1—Regulation of retinoblastoma protein—EP300—alcohol dependence	0.000246	0.00143	CbGpPWpGaD
Dabrafenib—RAF1—Transmembrane transport of small molecules—GABRB1—alcohol dependence	0.000238	0.00138	CbGpPWpGaD
Dabrafenib—RAF1—Transmission across Chemical Synapses—MAOA—alcohol dependence	0.000235	0.00136	CbGpPWpGaD
Dabrafenib—SLC22A6—SLC-mediated transmembrane transport—SLC6A3—alcohol dependence	0.000234	0.00135	CbGpPWpGaD
Dabrafenib—SLC22A8—SLC-mediated transmembrane transport—AVP—alcohol dependence	0.000232	0.00134	CbGpPWpGaD
Dabrafenib—SLCO1B1—Transmembrane transport of small molecules—GABRB1—alcohol dependence	0.000224	0.0013	CbGpPWpGaD
Dabrafenib—CYP3A4—Biological oxidations—ADH4—alcohol dependence	0.000223	0.00129	CbGpPWpGaD
Dabrafenib—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000221	0.00128	CbGpPWpGaD
Dabrafenib—CYP2C8—Biological oxidations—ALDH2—alcohol dependence	0.000218	0.00126	CbGpPWpGaD
Dabrafenib—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000217	0.00126	CbGpPWpGaD
Dabrafenib—RAF1—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—alcohol dependence	0.000217	0.00126	CbGpPWpGaD
Dabrafenib—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000217	0.00126	CbGpPWpGaD
Dabrafenib—RAF1—Neuronal System—GRIN2B—alcohol dependence	0.000216	0.00125	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—ADH1A—alcohol dependence	0.000216	0.00125	CbGpPWpGaD
Dabrafenib—ABCG2—HIF-1-alpha transcription factor network—EP300—alcohol dependence	0.000215	0.00124	CbGpPWpGaD
Dabrafenib—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000215	0.00124	CbGpPWpGaD
Dabrafenib—RAF1—Neuronal System—SLC6A3—alcohol dependence	0.000213	0.00124	CbGpPWpGaD
Dabrafenib—SLCO1B1—SLC-mediated transmembrane transport—SLC6A3—alcohol dependence	0.000213	0.00123	CbGpPWpGaD
Dabrafenib—SLC22A6—Transmembrane transport of small molecules—GABRA2—alcohol dependence	0.00021	0.00121	CbGpPWpGaD
Dabrafenib—ABCG2—Transmembrane transport of small molecules—GABRB1—alcohol dependence	0.000208	0.0012	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways in Glioblastoma—EP300—alcohol dependence	0.000207	0.0012	CbGpPWpGaD
Dabrafenib—RAF1—Transmembrane transport of small molecules—GABRA2—alcohol dependence	0.000203	0.00117	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—OPRK1—alcohol dependence	0.0002	0.00116	CbGpPWpGaD
Dabrafenib—SLC22A6—SLC-mediated transmembrane transport—AVP—alcohol dependence	0.000193	0.00112	CbGpPWpGaD
Dabrafenib—RAF1—Axon guidance—GRIN2B—alcohol dependence	0.000192	0.00111	CbGpPWpGaD
Dabrafenib—SLCO1B1—Transmembrane transport of small molecules—GABRA2—alcohol dependence	0.000191	0.00111	CbGpPWpGaD
Dabrafenib—CYP3A4—Biological oxidations—ADH7—alcohol dependence	0.00019	0.0011	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—WASF2—alcohol dependence	0.000188	0.00109	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—ADH4—alcohol dependence	0.000184	0.00107	CbGpPWpGaD
Dabrafenib—BRAF—Integrated Breast Cancer Pathway—EP300—alcohol dependence	0.000184	0.00106	CbGpPWpGaD
Dabrafenib—CYP3A4—Biological oxidations—GGT2—alcohol dependence	0.000182	0.00105	CbGpPWpGaD
Dabrafenib—RAF1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—alcohol dependence	0.000181	0.00105	CbGpPWpGaD
Dabrafenib—RAF1—Neuronal System—MAOA—alcohol dependence	0.00018	0.00104	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—WASF1—alcohol dependence	0.00018	0.00104	CbGpPWpGaD
Dabrafenib—ABCG2—Transmembrane transport of small molecules—GABRA2—alcohol dependence	0.000177	0.00102	CbGpPWpGaD
Dabrafenib—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000176	0.00102	CbGpPWpGaD
Dabrafenib—CYP2C8—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000176	0.00102	CbGpPWpGaD
Dabrafenib—SLCO1B1—SLC-mediated transmembrane transport—AVP—alcohol dependence	0.000176	0.00102	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—ADH6—alcohol dependence	0.000175	0.00102	CbGpPWpGaD
Dabrafenib—CYP2C8—Biological oxidations—CYP2E1—alcohol dependence	0.000174	0.00101	CbGpPWpGaD
Dabrafenib—CYP2C8—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000172	0.000997	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—OPRK1—alcohol dependence	0.000171	0.000988	CbGpPWpGaD
Dabrafenib—CYP3A4—Biological oxidations—ADH1B—alcohol dependence	0.000166	0.000963	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—ADH6—alcohol dependence	0.000162	0.000941	CbGpPWpGaD
Dabrafenib—SLCO1B3—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	0.000161	0.000931	CbGpPWpGaD
Dabrafenib—CYP2C8—Biological oxidations—GGT1—alcohol dependence	0.00016	0.000928	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	0.000159	0.000923	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—ADH7—alcohol dependence	0.000156	0.000906	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—GGT2—alcohol dependence	0.00015	0.000869	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—ADH1A—alcohol dependence	0.000145	0.000842	CbGpPWpGaD
Dabrafenib—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000145	0.00084	CbGpPWpGaD
Dabrafenib—CYP2C8—Biological oxidations—MAOA—alcohol dependence	0.000144	0.000831	CbGpPWpGaD
Dabrafenib—LIMK1—Developmental Biology—EP300—alcohol dependence	0.000142	0.000825	CbGpPWpGaD
Dabrafenib—SLC22A8—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	0.000142	0.000824	CbGpPWpGaD
Dabrafenib—RAF1—TGF-beta Signaling Pathway—EP300—alcohol dependence	0.000142	0.00082	CbGpPWpGaD
Dabrafenib—CYP3A4—Biological oxidations—MAOB—alcohol dependence	0.000138	0.000798	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—ADH1B—alcohol dependence	0.000137	0.000795	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—GRIN2B—alcohol dependence	0.000137	0.000794	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—ADH1A—alcohol dependence	0.000135	0.00078	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—OPRD1—alcohol dependence	0.000134	0.000778	CbGpPWpGaD
Dabrafenib—SLCO1B3—Transmembrane transport of small molecules—AVP—alcohol dependence	0.000133	0.00077	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—PDYN—alcohol dependence	0.000129	0.000746	CbGpPWpGaD
Dabrafenib—LIMK1—Innate Immune System—EP300—alcohol dependence	0.000126	0.000728	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—ADH4—alcohol dependence	0.000124	0.000716	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—CRHR1—alcohol dependence	0.00012	0.000693	CbGpPWpGaD
Dabrafenib—SLC22A6—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	0.000119	0.000688	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—OPRK1—alcohol dependence	0.000118	0.000684	CbGpPWpGaD
Dabrafenib—SLC22A8—Transmembrane transport of small molecules—AVP—alcohol dependence	0.000118	0.000682	CbGpPWpGaD
Dabrafenib—CYP3A4—Biological oxidations—ALDH2—alcohol dependence	0.000117	0.000678	CbGpPWpGaD
Dabrafenib—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000116	0.000675	CbGpPWpGaD
Dabrafenib—ABCB1—HIF-1-alpha transcription factor network—EP300—alcohol dependence	0.000116	0.000673	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—OPRD1—alcohol dependence	0.000115	0.000664	CbGpPWpGaD
Dabrafenib—RAF1—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	0.000115	0.000664	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—ADH4—alcohol dependence	0.000114	0.000663	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—MAOB—alcohol dependence	0.000114	0.000658	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—CHRM2—alcohol dependence	0.000113	0.000652	CbGpPWpGaD
Dabrafenib—ABCB1—Transmembrane transport of small molecules—GABRB1—alcohol dependence	0.000112	0.000651	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—PDYN—alcohol dependence	0.00011	0.000637	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—WASF2—alcohol dependence	0.000109	0.000634	CbGpPWpGaD
Dabrafenib—SLCO1B1—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	0.000108	0.000626	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	0.000107	0.00062	CbGpPWpGaD
Dabrafenib—RAF1—Integrated Pancreatic Cancer Pathway—EP300—alcohol dependence	0.000105	0.00061	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—ADH7—alcohol dependence	0.000105	0.000609	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—WASF1—alcohol dependence	0.000105	0.000607	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—OPRM1—alcohol dependence	0.000103	0.000599	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—CRHR1—alcohol dependence	0.000102	0.000592	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—WASF2—alcohol dependence	0.000102	0.000592	CbGpPWpGaD
Dabrafenib—BRAF—Disease—GOT2—alcohol dependence	0.000101	0.000586	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—ADH6—alcohol dependence	0.000101	0.000584	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—GGT2—alcohol dependence	0.000101	0.000584	CbGpPWpGaD
Dabrafenib—ABCG2—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	0.0001	0.000579	CbGpPWpGaD
Dabrafenib—SLC22A6—Transmembrane transport of small molecules—AVP—alcohol dependence	9.82e-05	0.000569	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—WASF1—alcohol dependence	9.8e-05	0.000568	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—ADH7—alcohol dependence	9.73e-05	0.000564	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—ALDH2—alcohol dependence	9.67e-05	0.00056	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—CHRM2—alcohol dependence	9.61e-05	0.000557	CbGpPWpGaD
Dabrafenib—ABCB1—Transmembrane transport of small molecules—GABRA2—alcohol dependence	9.55e-05	0.000553	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—NPY—alcohol dependence	9.51e-05	0.000551	CbGpPWpGaD
Dabrafenib—RAF1—Transmembrane transport of small molecules—AVP—alcohol dependence	9.49e-05	0.000549	CbGpPWpGaD
Dabrafenib—CYP3A4—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	9.44e-05	0.000547	CbGpPWpGaD
Dabrafenib—CYP3A4—Biological oxidations—CYP2E1—alcohol dependence	9.36e-05	0.000542	CbGpPWpGaD
Dabrafenib—CYP2C8—Biological oxidations—POMC—alcohol dependence	9.35e-05	0.000541	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—GGT2—alcohol dependence	9.33e-05	0.00054	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	9.3e-05	0.000538	CbGpPWpGaD
Dabrafenib—CYP3A4—Metapathway biotransformation—CYP2E1—alcohol dependence	9.24e-05	0.000535	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—ADH1B—alcohol dependence	9.22e-05	0.000534	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—HTR1B—alcohol dependence	9.18e-05	0.000531	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—CRH—alcohol dependence	9.18e-05	0.000531	CbGpPWpGaD
Dabrafenib—SLCO1B1—Transmembrane transport of small molecules—AVP—alcohol dependence	8.94e-05	0.000518	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—OPRM1—alcohol dependence	8.82e-05	0.000511	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—ADH6—alcohol dependence	8.79e-05	0.000509	CbGpPWpGaD
Dabrafenib—BRAF—Disease—GOT1—alcohol dependence	8.73e-05	0.000506	CbGpPWpGaD
Dabrafenib—CYP3A4—Biological oxidations—GGT1—alcohol dependence	8.6e-05	0.000498	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—ADH1B—alcohol dependence	8.54e-05	0.000494	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—ADH1A—alcohol dependence	8.36e-05	0.000484	CbGpPWpGaD
Dabrafenib—ABCG2—Transmembrane transport of small molecules—AVP—alcohol dependence	8.27e-05	0.000479	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—GOT2—alcohol dependence	8.22e-05	0.000476	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—NPY—alcohol dependence	8.12e-05	0.00047	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—DRD4—alcohol dependence	8.02e-05	0.000464	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—OPRD1—alcohol dependence	7.93e-05	0.00046	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—CRH—alcohol dependence	7.83e-05	0.000454	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—HTR1B—alcohol dependence	7.83e-05	0.000454	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—CYP2E1—alcohol dependence	7.73e-05	0.000448	CbGpPWpGaD
Dabrafenib—CYP3A4—Biological oxidations—MAOA—alcohol dependence	7.7e-05	0.000446	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—CNR1—alcohol dependence	7.66e-05	0.000444	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—MAOB—alcohol dependence	7.64e-05	0.000442	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—PDYN—alcohol dependence	7.61e-05	0.000441	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—DRD2—alcohol dependence	7.47e-05	0.000433	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—HTR7—alcohol dependence	7.47e-05	0.000433	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—EP300—alcohol dependence	7.32e-05	0.000424	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—ADH1A—alcohol dependence	7.28e-05	0.000422	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—ADH4—alcohol dependence	7.1e-05	0.000411	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—GGT1—alcohol dependence	7.1e-05	0.000411	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—GOT1—alcohol dependence	7.1e-05	0.000411	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—MAOB—alcohol dependence	7.07e-05	0.00041	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—WASF2—alcohol dependence	7.07e-05	0.00041	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—CRHR1—alcohol dependence	7.07e-05	0.00041	CbGpPWpGaD
Dabrafenib—RAF1—Disease—GOT2—alcohol dependence	7e-05	0.000405	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—DRD4—alcohol dependence	6.85e-05	0.000397	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—WASF1—alcohol dependence	6.78e-05	0.000393	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—CHRM2—alcohol dependence	6.65e-05	0.000385	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—CNR1—alcohol dependence	6.54e-05	0.000379	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—ALDH2—alcohol dependence	6.49e-05	0.000376	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—DRD2—alcohol dependence	6.38e-05	0.000369	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—HTR7—alcohol dependence	6.38e-05	0.000369	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—MAOA—alcohol dependence	6.36e-05	0.000368	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—AVP—alcohol dependence	6.29e-05	0.000364	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	6.25e-05	0.000362	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—ADH4—alcohol dependence	6.19e-05	0.000358	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	6.17e-05	0.000357	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	6.15e-05	0.000356	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—OPRM1—alcohol dependence	6.1e-05	0.000354	CbGpPWpGaD
Dabrafenib—RAF1—Disease—GOT1—alcohol dependence	6.04e-05	0.00035	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—ADH7—alcohol dependence	6.04e-05	0.00035	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—ALDH2—alcohol dependence	6.01e-05	0.000348	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—GGT2—alcohol dependence	5.79e-05	0.000335	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—NPY—alcohol dependence	5.62e-05	0.000325	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—GOT2—alcohol dependence	5.52e-05	0.00032	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—HTR1B—alcohol dependence	5.42e-05	0.000314	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—CRH—alcohol dependence	5.42e-05	0.000314	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—ADH6—alcohol dependence	5.41e-05	0.000313	CbGpPWpGaD
Dabrafenib—ABCB1—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	5.41e-05	0.000313	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—AVP—alcohol dependence	5.37e-05	0.000311	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—ADH1B—alcohol dependence	5.3e-05	0.000307	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—ADH7—alcohol dependence	5.26e-05	0.000305	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—HTR2A—alcohol dependence	5.23e-05	0.000303	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—CYP2E1—alcohol dependence	5.19e-05	0.000301	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—GOT2—alcohol dependence	5.11e-05	0.000296	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—GGT2—alcohol dependence	5.05e-05	0.000292	CbGpPWpGaD
Dabrafenib—CYP3A4—Biological oxidations—POMC—alcohol dependence	5.02e-05	0.000291	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—alcohol dependence	4.97e-05	0.000288	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—EP300—alcohol dependence	4.92e-05	0.000285	CbGpPWpGaD
Dabrafenib—RAF1—Hemostasis—EP300—alcohol dependence	4.83e-05	0.00028	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—CYP2E1—alcohol dependence	4.81e-05	0.000278	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—GOT1—alcohol dependence	4.77e-05	0.000276	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—GGT1—alcohol dependence	4.77e-05	0.000276	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—DRD4—alcohol dependence	4.74e-05	0.000274	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—ADH1B—alcohol dependence	4.61e-05	0.000267	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—CNR1—alcohol dependence	4.52e-05	0.000262	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—ADH1A—alcohol dependence	4.48e-05	0.00026	CbGpPWpGaD
Dabrafenib—ABCB1—Transmembrane transport of small molecules—AVP—alcohol dependence	4.47e-05	0.000259	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—HTR2A—alcohol dependence	4.47e-05	0.000259	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—GOT1—alcohol dependence	4.41e-05	0.000256	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—GGT1—alcohol dependence	4.41e-05	0.000256	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—HTR7—alcohol dependence	4.41e-05	0.000256	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—DRD2—alcohol dependence	4.41e-05	0.000256	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—MAOB—alcohol dependence	4.39e-05	0.000254	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—EP300—alcohol dependence	4.35e-05	0.000252	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—MAOA—alcohol dependence	4.27e-05	0.000247	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—POMC—alcohol dependence	4.18e-05	0.000242	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	4.14e-05	0.00024	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—POMC—alcohol dependence	4.14e-05	0.00024	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—MAOA—alcohol dependence	3.96e-05	0.000229	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—MAOB—alcohol dependence	3.82e-05	0.000221	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—ADH4—alcohol dependence	3.81e-05	0.000221	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—ALDH2—alcohol dependence	3.73e-05	0.000216	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—AVP—alcohol dependence	3.72e-05	0.000215	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	3.59e-05	0.000208	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—POMC—alcohol dependence	3.57e-05	0.000207	CbGpPWpGaD
Dabrafenib—BRAF—Disease—EP300—alcohol dependence	3.38e-05	0.000196	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—ALDH2—alcohol dependence	3.25e-05	0.000188	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—ADH7—alcohol dependence	3.24e-05	0.000188	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—GOT2—alcohol dependence	3.17e-05	0.000184	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—GGT2—alcohol dependence	3.11e-05	0.00018	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—HTR2A—alcohol dependence	3.09e-05	0.000179	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—CYP2E1—alcohol dependence	2.98e-05	0.000173	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—ADH1B—alcohol dependence	2.84e-05	0.000165	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—POMC—alcohol dependence	2.78e-05	0.000161	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—GOT2—alcohol dependence	2.76e-05	0.00016	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—EP300—alcohol dependence	2.75e-05	0.000159	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—GOT1—alcohol dependence	2.74e-05	0.000159	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—GGT1—alcohol dependence	2.74e-05	0.000159	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—CYP2E1—alcohol dependence	2.6e-05	0.000151	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—POMC—alcohol dependence	2.58e-05	0.000149	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—EP300—alcohol dependence	2.53e-05	0.000147	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—POMC—alcohol dependence	2.47e-05	0.000143	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—MAOA—alcohol dependence	2.45e-05	0.000142	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—GGT1—alcohol dependence	2.39e-05	0.000138	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—GOT1—alcohol dependence	2.39e-05	0.000138	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	2.38e-05	0.000138	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—EP300—alcohol dependence	2.37e-05	0.000137	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—MAOB—alcohol dependence	2.36e-05	0.000136	CbGpPWpGaD
Dabrafenib—RAF1—Disease—EP300—alcohol dependence	2.34e-05	0.000135	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—MAOA—alcohol dependence	2.14e-05	0.000124	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—ALDH2—alcohol dependence	2e-05	0.000116	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—EP300—alcohol dependence	1.85e-05	0.000107	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—EP300—alcohol dependence	1.71e-05	9.89e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—GOT2—alcohol dependence	1.7e-05	9.86e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—EP300—alcohol dependence	1.64e-05	9.48e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—CYP2E1—alcohol dependence	1.6e-05	9.27e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—POMC—alcohol dependence	1.6e-05	9.26e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—GGT1—alcohol dependence	1.47e-05	8.52e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—GOT1—alcohol dependence	1.47e-05	8.52e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—POMC—alcohol dependence	1.39e-05	8.06e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—MAOA—alcohol dependence	1.32e-05	7.63e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—EP300—alcohol dependence	1.06e-05	6.14e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—EP300—alcohol dependence	9.24e-06	5.35e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—POMC—alcohol dependence	8.58e-06	4.97e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—EP300—alcohol dependence	5.69e-06	3.3e-05	CbGpPWpGaD
